Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 26 May 2016

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Eosinophilic esophagitis in the transition from childhood to adulthood

Published ahead of print, a study in the Alimentary Pharmacology & Therapeutics reports the natural history of eosinophilic esophagitis in the transition from childhood to adulthood.

News image

Dr Menard-Katcher and colleagues performed a cross-sectional study of eosinophilic esophagitis patients from the Children's Hospital of Philadelphia eosinophilic esophagitis registry.

The team determined the prevalence of eosinophilic esophagitis symptoms, and impact of eosinophilic esophagitis on quality of life among adults diagnosed with eosinophilic esophagitis during childhood.

Patients 18 years diagnosed with eosinophilic esophagitis during childhood were administered validated dysphagia and Quality of Life questionnaires.

Ongoing eosinophilic esophagitis treatments were ascertained.

The team of doctors identified a total of 140 eosinophilic esophagitis patients 18 years, of which 53 completed all questions.

Only 6 subjects had positive or indeterminate dysphagia scores.

76% were following allergy directed diets
Alimentary Pharmacology & Therapeutics

The researchers found that however, of 47 patients with negative scores, 18 reported ongoing difficulty swallowing.

The mean PAGI-QOL score was 4.58/5.

The researchers investigated that the the dietary dimension score was 3.7/5.

Current pharmacological eosinophilic esophagitis treatments were topical steroids, and interleukin-5 antagonists.

Additionally, 26 out of 53 were on PPI therapy, and 76% were following allergy directed diets.

The team found that the majority of young adults diagnosed with eosinophilic esophagitis during childhood continue to require pharmacological treatment and/or dietary modification for eosinophilic esophagitis.

Dr Menard-Katcher's team concludes "A substantial proportion of this population experiences ongoing swallowing difficulties that a standard dysphagia questionnaire fails to capture."

"Dietary quality of life, but not total quality of life, appears to be adversely affected."

"These data suggest that eosinophilic esophagitis diagnosed during childhood remains a significant medical issue during early adulthood, and that better eosinophilic esophagitis symptom measurement instruments are needed."

Alimentary Pharmacology & Therapeutics 2013:37(1): 114-121
12 December 2012

Go to top of page Email this page Email this page to a colleague

 26 May 2016 
Direct-acting antivirals in Hep C cirrhosis
 26 May 2016 
Education booklet for colonoscopy bowel preparation
 26 May 2016 
Uncomplicated diverticulitis in outpatients
 25 May 2016 
Recurrence of Barrett’s after successful endoscopic therapy
 25 May 2016 
Preventing NSAID-associated GI toxicity
 25 May 2016 
PPIs and NSAID-induced small bowel injury
 24 May 2016 
Fecal inflammatory markers in Crohn's
 24 May 2016 
Depression and IBD recurrence
 24 May 2016 
New therapies for NASH
 23 May 2016 
Risk factors for peptic ulcer bleeding outcomes
 23 May 2016 
Liver transplantation for hepatocellular carcinoma
 23 May 2016 
Cancer after colectomy in IBD
 20 May 2016 
Biomarker for colorectal cancer diagnosis
 20 May 2016 
Prognostic score for hepatic venous outflow obstruction
 20 May 2016 
Treatment for uncomplicated acute diverticulitis
 19 May 2016 
Probiotics and H. pylori eradication
 19 May 2016 
Impaired skeletal health in atrophic gastritis
 19 May 2016 
Predicting outcome in ulcerative colitis
 18 May 2016 
Erectile dysfunction in IBD
 18 May 2016 
Surgical fundoplication for GERD 
 18 May 2016 
Acute GERD and esophageal histologic changes
 17 May 2016 
Vitamin D level and clinical status in IBD 
 17 May 2016 
Mucosal dysbiosis in Crohn's disease
 17 May 2016 
Inpatient costs for IBD and acute pancreatitis
 16 May 2016 
Outcomes of postcolonoscopy colorectal cancers
 16 May 2016 
C. difficile in ulcerative colitis patients
 16 May 2016 
Therapy for Crohn's in a Medicaid population
 13 May 2016 
Parkinson's disease and IBD
 13 May 2016 
Non-traditional heart disease risk factors in NAFLD
 13 May 2016 
Inactivated oral cholera vaccine
 12 May 2016 
Gestational diabetes mellitus and NAFLD
 12 May 2016 
Impact of Crohn's in the USA
 12 May 2016 
Ozanimod induction and ulcerative colitis
 11 May 2016 
Anti-TNF discontinuation in IBD
 11 May 2016 
Age and disease presentation with Crohn's disease
 11 May 2016 
Prognosis after colorectal cancer resection
 10 May 2016 
Gluten-free diet in patients with IBS-diarrhea
 10 May 2016 
Noninvasive test for IBD
 10 May 2016 
Digital health for gastroenterology
 09 May 2016 
Diarrheal infections in adults
 09 May 2016 
Quality improvement initiative and readmission for cirrhosis
 09 May 2016 
Coffee or tea and the risk of Barrett's
 06 May 2016 
Risk factors in peptic ulcer bleeding
 06 May 2016 
Recurrent pancreatitis after acute pancreatitis
 06 May 2016 
Managing acute lower GI bleeding
 05 May 2016 
Chemoradiotherapy vs chemotherapy for pancreatic cancer
 05 May 2016 
Genetics in early-early-onset IBD
 05 May 2016 
Reductions in quality of screening colonoscopies
 04 May 2016 
Anti-TNF therapy for IBD
 04 May 2016 
Bismuth and H. pylori eradication
 04 May 2016 
Chromoendoscopy vs colonoscopy for dysplasia in colitis
 03 May 2016 
Surgery vs medical therapy for GERD
 03 May 2016 
Vedolizumab for IBD
 03 May 2016 
PPIs and gut microbiota
 02 May 2016 
Genetic variant that increase NAFLD risk
 02 May 2016 
Resection of colorectal polyps
 02 May 2016 
Mycophenolate mofetil as first-line treatment of autoimmune hepatitis
 29 April 2016 
Crohn's disease associated genes
 29 April 2016 
Simvastatins and survival in cirrhosis
 29 April 2016 
HCV infection in Baby Boomers with Medicare

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2016 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us